本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

13.60
-0.2200-1.59%
盤後13.910.3100+2.28%19:46 EDT
成交量:208.10萬
成交額:2,856.97萬
市值:16.21億
市盈率:-13.07
高:14.13
開:13.94
低:13.54
收:13.82
資料載入中...
2021/11/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/07

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/07

持股變動聲明

3/A [Amend] - Initial statement of beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/07

重要事件披露

8-K - Current report
2021/08/05

重要事件披露

8-K - Current report
2021/08/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/14

重要事件披露

8-K - Current report
2021/05/12

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/04

重要事件披露

8-K - Current report
2021/04/23

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/26

重要事件披露

8-K - Current report
2021/02/16

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

重要事件披露

8-K - Current report
2021/02/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/08

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership